Shares of Healthcare sector company Ionis Pharmaceuticals moved -6.0% today, and are now trading at a price of $38.1. The mid-cap stock's daily volume was 1,114,801 compared to its average volume of 1,046,319. The S&P 500 index returned a 0.3% performance.
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company is based in Carlsbad and has 660 full time employees. Its market capitalization is $5,380,100,608.
19 analysts are following Ionis Pharmaceuticals and have set target prices ranging from $22 to $92 per share. On average, they have given the company a rating of hold. At today's prices, IONS is trading -23.97% away from its average analyst target price of $50.11 per share.
|Date Reported||Cash Flow from Operations ($ MM)||Capital expenditures ($ MM)||Free Cash Flow ($ MM)||YoY Growth (%)|